143 related articles for article (PubMed ID: 23565615)
1. Histological improvement of long-term antiviral therapy in chronic hepatitis B patients with persistently normal alanine aminotransferase levels.
Du X; Wang J; Shao L; Hu X; Yang C; Shen L; Weng X; Zhang W
J Viral Hepat; 2013 May; 20(5):328-35. PubMed ID: 23565615
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels.
Park JY; Park YN; Kim DY; Paik YH; Lee KS; Moon BS; Han KH; Chon CY; Ahn SH
J Viral Hepat; 2008 Aug; 15(8):615-21. PubMed ID: 18573162
[TBL] [Abstract][Full Text] [Related]
3. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.
Chang TT; Liaw YF; Wu SS; Schiff E; Han KH; Lai CL; Safadi R; Lee SS; Halota W; Goodman Z; Chi YC; Zhang H; Hindes R; Iloeje U; Beebe S; Kreter B
Hepatology; 2010 Sep; 52(3):886-93. PubMed ID: 20683932
[TBL] [Abstract][Full Text] [Related]
4. Histological outcome for chronic hepatitis B patients treated with entecavir vs lamivudine-based therapy.
Wang JL; Du XF; Chen SL; Yu YQ; Wang J; Hu XQ; Shao LY; Chen JZ; Weng XH; Zhang WH
World J Gastroenterol; 2015 Aug; 21(32):9598-606. PubMed ID: 26327767
[TBL] [Abstract][Full Text] [Related]
5. On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients.
Wong GL; Wong VW; Choi PC; Chan AW; Chim AM; Yiu KK; Chu SH; Chan FK; Sung JJ; Chan HL
Antivir Ther; 2011; 16(2):165-72. PubMed ID: 21447865
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis B.
Alam S; Ahmad N; Mustafa G; Shrestha A; Alam AK; Khan M
Liver Int; 2011 Jul; 31(6):824-30. PubMed ID: 21645213
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of significant liver fibrosis and cirrhosis in chronic hepatitis B patients with normal ALT in central Europe.
Göbel T; Erhardt A; Herwig M; Poremba C; Baldus SE; Sagir A; Heinzel-Pleines U; Häussinger D
J Med Virol; 2011 Jun; 83(6):968-73. PubMed ID: 21503908
[TBL] [Abstract][Full Text] [Related]
8. Age as a predictor of significant fibrosis features in HBeAg-negative chronic hepatitis B virus infection with persistently normal alanine aminotransferase.
Tan Y; Ye Y; Zhou X; Chen L; Wen D
PLoS One; 2015; 10(4):e0123452. PubMed ID: 25885705
[TBL] [Abstract][Full Text] [Related]
9. Significant hepatic histopathology in chronic hepatitis B patients with serum ALT less than twice ULN and high HBV-DNA levels in Indonesia.
Lesmana CR; Gani RA; Hasan I; Simadibrata M; Sulaiman AS; Pakasi LS; Budihusodo U; Krisnuhoni E; Lesmana LA
J Dig Dis; 2011 Dec; 12(6):476-80. PubMed ID: 22118698
[TBL] [Abstract][Full Text] [Related]
10. Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase.
Sánchez-Conde M; Berenguer J; Miralles P; Alvarez F; Carlos Lopez J; Cosin J; Pilar C; Ramirez M; Gutierrez I; Alvarez E
Clin Infect Dis; 2006 Sep; 43(5):640-4. PubMed ID: 16886160
[TBL] [Abstract][Full Text] [Related]
11. [Histological changes in the livers of chronic hepatitis B patients with persistently normal serum alanine transaminase levels].
Gui HL; Xie Q; Wang H; Cai W; Lin ZM; Jiang S; Xu P; Zhou XQ; Guo Q; Yu H
Zhonghua Gan Zang Bing Za Zhi; 2007 Dec; 15(12):881-5. PubMed ID: 18171518
[TBL] [Abstract][Full Text] [Related]
12. Long-term lamivudine treatment achieves regression of advanced liver fibrosis/cirrhosis in patients with chronic hepatitis B.
Xu B; Lin L; Xu G; Zhuang Y; Guo Q; Liu Y; Wang H; Zhou X; Wu S; Bao S; Cai W; Xie Q
J Gastroenterol Hepatol; 2015 Feb; 30(2):372-8. PubMed ID: 25167956
[TBL] [Abstract][Full Text] [Related]
13. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
[TBL] [Abstract][Full Text] [Related]
14. Significant changes in liver stiffness measurements in patients with chronic hepatitis B: 3-year follow-up study.
Fung J; Lai CL; Wong DK; Seto WK; Hung I; Yuen MF
J Viral Hepat; 2011 Jul; 18(7):e200-5. PubMed ID: 21692933
[TBL] [Abstract][Full Text] [Related]
15. Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: a retrospective, multicenter, nonrandomized, open-label study.
Pellicelli AM; Barbaro G; Francavilla R; Romano M; Barbarini G; Mazzoni E; Mecenate F; Paffetti A; Barlattani A; Struglia C; Villani R; Nauri L; Nosotti L; Armignacco O; Ferri F; Camporiondo MP; Soccorsi F;
Clin Ther; 2008 Feb; 30(2):317-23. PubMed ID: 18343270
[TBL] [Abstract][Full Text] [Related]
16. Two patterns of alanine aminotransferase increase to predict long-term viral response in chronic hepatitis B patients: virus- or host-induced?
You H; Wu X; Ou X; Ma H; Wang Q; Liu T; Cong M; Wang P; Wang B; Jia J
Antivir Ther; 2011; 16(3):299-307. PubMed ID: 21555812
[TBL] [Abstract][Full Text] [Related]
17. A scoring system for predicting significant fibrosis in chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase levels.
Wang H; Yan R; Zhou Y; Wang MS; Ruo GQ; Cheng MJ
J Clin Gastroenterol; 2015 Jan; 49(1):69-75. PubMed ID: 24518795
[TBL] [Abstract][Full Text] [Related]
18. Effect of long-term lamivudine in chronic hepatitis B virus-infected children.
Ozgenç F; Arikan C; Sertoz RY; Nart D; Aydogdu S; Yagci RV
Antivir Ther; 2004 Oct; 9(5):729-32. PubMed ID: 15535410
[TBL] [Abstract][Full Text] [Related]
19. [Accuracy of FibroScan for the diagnosis of liver fibrosis influenced by serum alanine aminotransferase levels in patients with chronic hepatitis B].
Chen XB; Zhu X; Chen LY; Chen EQ; Tang H
Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):286-90. PubMed ID: 21586228
[TBL] [Abstract][Full Text] [Related]
20. Response to long-term lamivudine treatment (up to 5 years) in patients with severe chronic hepatitis B, role of genotype and drug resistance.
Moskovitz DN; Osiowy C; Giles E; Tomlinson G; Heathcote EJ
J Viral Hepat; 2005 Jul; 12(4):398-404. PubMed ID: 15985011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
